InvestorsHub Logo
Followers 39
Posts 2767
Boards Moderated 0
Alias Born 02/08/2014

Re: The ELTP King post# 370879

Friday, 07/01/2022 11:23:17 AM

Friday, July 01, 2022 11:23:17 AM

Post# of 403264
Again, from Q3 transcript
"For 2022, we have two products under review by FDA, both are licensed products co-developed with partners. We expect approval for one during the first half of 2022."

Whether you consider it a partnership Nasrat definitely did.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News